Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume 22, 14 Issues, 2022
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
Contents
Endocrine, Metabolic & Immune Disorders - Drug Targets , Volume 8 - Number 2
Efficacy of Dietary Supplementation with Botanicals on Carbohydrate Metabolism in Humans
, 8(2): 78 - 81William T. Cefalu, Jianping Ye and Zhong Q. Wang
DOI: 10.2174/187153008784534376
Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications
, 8(2): 89 - 98Ling Liu, Yu Wang, Karen S.L. Lam and Aimin Xu
DOI: 10.2174/187153008784534385
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
, 8(2): 99 - 111Jun Yin, Hanjie Zhang and Jianping Ye
DOI: 10.2174/187153008784534330
Male Contraception: An Overview of the Potential Target Events
, 8(2): 122 - 131Daulat R.P. Tulsiani and Aida Abou-Haila
DOI: 10.2174/187153008784534321
Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
, 8(2): 132 - 142Sonemany Salinthone, Vijayshree Yadav, Dennis N. Bourdette and Daniel W. Carr
DOI: 10.2174/187153008784534303
Editor-in-Chief
Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)
Biography
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Biography
Biography of Emilio Jirillo
Emilio Jirillo is full professor of Immunology at University of Bari Medical School (Bari, Italy) since 1986.His current fields of interest are: mucosal immunity, microbial immunity and immunonutrition. Especially in this last field, he has recently published in vitro and in vivo studies on the anti-inflammatory effects of polyphenols. He is author of more than 560 papers (326 scientific papers are listed in PUBMED), including books and chapters of books. He is also editor-in-chief- of another Bentham journal: Clinical Immunology Endocrine Metabolic Drugs.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Advertisement
Webmaster Contact: info@benthamscience.net